ArticleInternational journal of women's health2026
A Cross-Sectional Analysis of Women Attending a Free Screening Mammography Campaign at a University Hospital in Lebanon.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Breast cancer is the most common malignancy among Lebanese women; however, local data on demographic, reproductive, and hormonal factors associated with breast cancer history are scarce. This study aimed to assess the characteristics of Lebanese women attending a mammography screening campaign and identify factors associated with a personal history of breast cancer in this population. Methods: A cross-sectional study was conducted among 380 women attending a free mammography screening campaign at the Lebanese American University Medical Center-Rizk Hospital, Beirut, Lebanon. All women underwent 2D mammography and 3D digital breast tomosynthesis. Participants (enrolled between January 2022-April 2022) completed a questionnaire assessing demographics, medical history, reproductive factors, and lifestyle variables. Associations between personal history of breast cancer and categorical variables were assessed using Chi-square and Fisher's exact tests, while Mann-Whitney Results: The mean age was 54.5 ± 9.0 years. Thirteen women (3.4% [95% CI: 2.0%-5.7%]) had a previous personal history of breast cancer. BI-RADS 2D classifications were category 0 in 190 women (50.0%), category 1 in 7 (1.8%), category 2 in 177 (46.6%), category 3 in 2 (0.5%), and category 4 in 2 (0.5%) of women. BI-RADS 3D classifications showed category 0 in 76 women (20.0%), category 1 in 8 (2.1%), category 2 in 290 (76.3%), category 3 in 2 (0.5%), and category 4 in 2 (0.5%) of women. The use of hormone replacement therapy (HRT) was significantly associated with breast cancer history (ORa 6.052-7.146, p = 0.010-0.031), remaining significant across adjusted models. Older age was significant in models excluding menopausal factors (ORa 1.075-1.111 per year), but attenuated when HRT was included. Family history, reproductive factors, lifestyle variables, and breast density showed no significant associations. Conclusion: HRT use and older age were significantly associated with breast cancer history in this Lebanese screening population. Higher-risk groups may benefit from complementary imaging techniques. Larger multicenter studies are warranted to confirm these findings and identify additional risk factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.